MECHANISMS OF RAS PATHWAY ACTIVATION IN HCC PATIENTS, AND COMBINATION THERAPIES BLOCKING RAS (SORAFENIB) AND MTOR PATHWAYS (RAPAMYCIN) IN VIVO


Newell P., Toffanin S., Villanueva A., Chiang D. Y. , Cabellos L., Lim K. H. , ...Daha Fazla

59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San-Francisco, Kostarika, 31 Ekim - 04 Kasım 2008, cilt.48 identifier

  • Cilt numarası: 48
  • Basıldığı Şehir: San-Francisco
  • Basıldığı Ülke: Kostarika